Diabetic Ketoacidosis Causes and Risk Factors

Core Pathophysiologic Mechanism

• The American Diabetes Association notes that DKA is caused by absolute or relative insulin deficiency combined with elevated counterregulatory hormones, which together trigger uncontrolled lipolysis and ketogenesis 1, 2
• Reduced effective insulin action leads to impaired glucose utilization in peripheral tissues and increased hepatic/renal glucose production, resulting in hyperglycemia, as stated by the American Diabetes Association 1, 2
• Elevated counterregulatory hormones combined with insulin deficiency trigger release of free fatty acids from adipose tissue and drive unregulated hepatic ketone production, according to the American Diabetes Association 1, 2

Most Common Precipitating Factors

• Infection is the single most common precipitating cause of DKA, as reported by the American Diabetes Association 1, 2
• The American Diabetes Association recommends that infection be considered a leading precipitating factor in established diabetes 1, 2

Medication-Induced DKA

• SGLT2 inhibitors are now a leading cause of DKA, including euglycemic DKA, particularly as their use expands to heart failure and chronic kidney disease in non-diabetic patients, according to the American Association of Clinical Endocrinologists 3
• The mechanism involves reduction in insulin doses due to improved glycemic control, increased glucagon levels leading to enhanced lipolysis and ketone production, decreased renal clearance of ketones, and risk present in both diabetic and non-diabetic patients, as stated by the American Association of Clinical Endocrinologists 3

High-Risk Clinical Scenarios

• Acute illness or febrile illness increases insulin requirements through stress hormone elevation, as reported by the American Diabetes Association 1
• Reduced caloric intake is particularly dangerous in patients on SGLT2 inhibitors, according to the American Association of Clinical Endocrinologists 3
• Pregnancy, especially in type 1 diabetes, with up to 2% of pregnancies complicated by DKA, is a high-risk scenario, as stated by the American College of Obstetricians and Gynecologists 3

Special Populations at Risk

• Elderly individuals in chronic care facilities who become hyperglycemic and cannot access fluids are at risk, as reported by the American Geriatrics Society 1
• Patients with autoimmunity initially thought to have type 2 diabetes are also at risk, according to the American Association of Clinical Endocrinologists 3

DKA Precipitating Factors with Dapagliflozin

Pathophysiology

• The body's compensatory response to glucose depletion involves counterregulatory hormone release to raise blood glucose, glycogenolysis, and gluconeogenesis to restore normoglycemia, which are protective mechanisms, according to the American Diabetes Association 4

Clinical Presentation

• Traditional DKA teaching emphasizes glucose >250 mg/dL, but SGLT2 inhibitor-induced DKA presents with severe metabolic acidosis, elevated anion gap, positive ketones in blood and urine, and blood glucose 177-180 mg/dL or even lower, as reported in Diabetes Care 4

Diabetic Ketoacidosis Precipitating Factors

Patient-Related Factors

• Recurrent DKA is almost always due to insulin omission, with higher incidence in patients with psychiatric illness, those from single-parent homes, and underinsured patients, according to the American Diabetes Association 5
• Psychological problems and lack of financial resources are the most common causes of DKA in patients with established diabetes, as reported by the American Diabetes Association 5
• Children and adolescents with eating disorders have a higher frequency of recurrent DKA, as noted by the American Diabetes Association 5

Disease-Related Factors

• First presentation of type 1 diabetes, particularly in children and adolescents, may present with ketoacidosis as the initial manifestation, according to the American Diabetes Association 6
• Some patients with new-onset diabetes retain residual β-cell function initially but eventually become insulin-dependent and at risk for ketoacidosis, as reported by the American Diabetes Association 6

Elevated WBC in Diabetic Ketoacidosis

Characterization of Leukocytosis

• The leukocytosis in DKA is typically characterized by predominance of immature and mature granulocytes (left shift), which is expected in the acute inflammatory state of DKA, according to the American Heart Association 7

Distinguishing Infection from Stress Response

• Temperature is unreliable in DKA patients, as they can be normothermic or even hypothermic despite serious infection, and hypothermia is actually a poor prognostic sign, as stated by the American Diabetes Association 8
• Procalcitonin is more specific than WBC for bacterial infection in DKA patients and should be obtained if infection is suspected, although the strength of evidence is not provided 8
• The American Diabetes Association recommends obtaining cultures (blood, urine, throat) and initiating appropriate antibiotics empirically if clinical suspicion for infection exists, rather than waiting for WBC normalization, with a moderate strength of evidence 8
• Leukopenia or lymphocyte predominance suggests an alternative diagnosis entirely and makes DKA less likely, according to the American Heart Association 7

Other Causes of WBC Elevation in DKA

• Medication-induced stress, such as corticosteroids, sympathomimetic agents (dobutamine, terbutaline), and thiazides, can precipitate DKA and independently elevate WBC counts, as reported by the American Diabetes Association 8

Precipitating Factors for Diabetic Ketoacidosis

Primary Precipitating Factors

• Urban African-Americans are at risk of discontinuing insulin due to economic reasons, contributing to DKA cases 9
• The American Diabetes Association recommends educating patients on sick-day management, including contacting their provider when blood glucose exceeds 300 mg/dL, using supplemental short-acting insulin, and maintaining a liquid diet with carbohydrates and salt 9

Prevention Strategies

• The American Diabetes Association suggests addressing economic barriers to insulin access, particularly in urban African-American populations, to prevent DKA 9
• Ensuring elderly patients in chronic care facilities have adequate supervision and fluid access is crucial in preventing DKA, as recommended by the American Geriatrics Society 9

Rapid Onset of Diabetic Ketoacidosis: Cited Evidence

High‑Risk Scenarios

• Insulin pump failure or disconnection creates an immediate lack of continuous rapid‑acting insulin, leading to absolute insulin deficiency and the development of diabetic ketoacidosis (DKA) within a few hours. 10
• Interruption of any insulin delivery (e.g., pump malfunction or missed injections) can precipitate DKA rapidly, often within 4–10 hours depending on the insulin formulation used. 11

Age‑Related Vulnerability

• Children and adolescents experience the fastest progression to DKA because β‑cell destruction is most rapid in this age group; DKA frequently presents as the first manifestation of type 1 diabetes and can evolve from modest hyperglycemia to severe DKA within hours, especially when infection or other stressors are present. 10, 12
• Incidence trends show that DKA rates among U.S. children and adolescents have risen dramatically over the past two decades, highlighting a growing public‑health concern in this population. 10, 12

Insulin Management Recommendations

• Basal insulin should never be discontinued, even when blood glucose appears normal, because stopping basal insulin markedly increases the risk of rapid ketosis and DKA within 4–10 hours, varying with the type of insulin (rapid‑acting analogues vs. human soluble insulin). 11

Precipitating Factors and Clinical Manifestations of Ketoacidosis

Pathophysiologic Mechanism

• Hepatic β‑oxidation of free fatty acids generates excess ketone bodies (acetoacetate, β‑hydroxybutyrate, acetone), leading to ketoacidosis. 13
• Accumulation of ketone bodies lowers blood pH, producing metabolic acidosis. 13

Most Common Precipitating Factors

• Infection is the leading precipitant of ketoacidosis, accounting for 30–50 % of cases across all age groups. 13
• In infection‑related ketoacidosis, patients may present with normothermia or hypothermia; hypothermia signals a poorer prognosis. 13

Insulin‑Related Issues

• Abrupt discontinuation or inadequate dosing of insulin in individuals with established type 1 diabetes frequently precipitates ketoacidosis. 13

New‑Onset Diabetes in Vulnerable Populations

• First presentation of diabetes in elderly residents of chronic‑care facilities can trigger hyperglycemic crises and ketoacidosis. 13

Medication‑Induced Triggers

• Systemic corticosteroid therapy can disturb carbohydrate metabolism and precipitate ketoacidosis. 13
• Use of thiazide diuretics may provoke hyperglycemic crises that evolve into ketoacidosis. 13
• Administration of sympathomimetic agents (e.g., dobutamine, terbutaline) has been associated with ketoacidosis onset. 13

Acute Medical Conditions

• Myocardial infarction can precipitate ketoacidosis through acute elevation of stress hormones. 13
• Cerebrovascular accidents are recognized triggers for ketoacidosis. 13
• Acute pancreatitis may initiate ketoacidosis in susceptible patients. 13
• Trauma increases insulin requirements via the stress response, raising the risk of ketoacidosis. 13
• Alcohol abuse is a documented precipitating factor for ketoacidosis. 13

Clinical Pitfalls and Diagnostic Considerations

• Body temperature is unreliable for diagnosing infection‑related ketoacidosis; patients may be normothermic or hypothermic despite serious infection. 13
• Abdominal pain in the setting of ketoacidosis can be either a cause or a consequence and warrants further evaluation if it does not resolve with standard therapy. 13

Diabetic Ketoacidosis: Precipitating Factors and Differences Between Diabetes Types

Precipitating Factors in Established Type 1 Diabetes

• According to the American Diabetes Association, omission or inadequate dosing of insulin is a frequent precipitant of diabetic ketoacidosis (DKA) in patients with established type 1 diabetes, often associated with psychosocial problems, limited financial resources, or eating‑disorder behaviors. 14

First Presentation of Type 1 Diabetes

• The American Diabetes Association notes that DKA can be the initial clinical manifestation of newly diagnosed type 1 diabetes, particularly in children and adolescents. 14

Pathophysiology in Type 1 Diabetes

• The American Diabetes Association explains that DKA in type 1 diabetes arises from autoimmune destruction of pancreatic β‑cells, leading to absolute insulin deficiency. [14][15]

Pathophysiology in Type 2 Diabetes

• The American Diabetes Association states that DKA is rare in type 2 diabetes when it occurs spontaneously; it is usually triggered by acute stressors such as infection, other serious illnesses, insulin deficiency in patients already receiving insulin, or the use of SGLT2 inhibitors. 16

Risk Factors and Triggers for Diabetic Ketoacidosis

Infectious Triggers

• Infection is the single most common precipitating factor for DKA, accounting for 30‑50 % of cases, with urinary tract infections and pneumonia being the predominant infections. 17
• Urinary tract infections and pneumonia together represent the majority of infection‑related DKA episodes. 17

Insulin Management Issues

• Discontinuation of basal insulin—even when the patient is not eating—can precipitate DKA within 4–10 hours; basal insulin should never be stopped. 18

New‑Onset Diabetes

• The first clinical presentation of type 1 diabetes frequently manifests as DKA. 17
• Approximately 25 % of individuals newly diagnosed with type 1 diabetes present in DKA. 17

SGLT2‑Inhibitor‑Associated DKA

• SGLT2 inhibitors have become a leading cause of DKA, including euglycemic DKA (glucose < 200 mg/dL), with an incidence of 0.6–4.9 events per 1,000 patient‑years. 18
• In randomized controlled trials, SGLT2 inhibitors increase the relative risk of DKA 2.46‑fold (95 % CI 1.16–5.21) compared with placebo. Level A evidence (RCT). 18
• Very‑low‑carbohydrate diets or prolonged fasting markedly raise the risk of SGLT2‑inhibitor‑associated DKA. 18
• Dehydration and volume depletion are additional risk enhancers for DKA in patients on SGLT2 inhibitors. 18
• Excessive alcohol consumption further elevates the risk of DKA when using SGLT2 inhibitors. 18
• Underlying autoimmunity (e.g., latent autoimmune diabetes in adults misdiagnosed as type 2) predisposes to DKA with SGLT2‑inhibitor therapy. 18
• Acute illness or infection acts as a trigger for DKA in patients receiving SGLT2 inhibitors. 18

Other Acute Medical Conditions

• Myocardial infarction can precipitate DKA through acute stress‑hormone elevation. 17
• Cerebrovascular accidents are recognized triggers of DKA. 17
• Acute pancreatitis may initiate DKA. 17
• Trauma increases insulin requirements via the stress response, leading to DKA. 17
• Major surgery creates catabolic stress that can trigger DKA. 17

High‑Risk Populations

• Up to 2 % of pregnancies complicated by pre‑gestational diabetes (most often type 1) are complicated by DKA. 18
• Pregnant individuals may develop euglycemic DKA (glucose < 200 mg/dL). 18
• The incidence of DKA in gestational diabetes is low, <0.1 %. 18
• Elderly patients with DKA experience higher mortality rates compared with younger cohorts. 17

Alcohol and Substance Use

• Alcohol abuse is a documented precipitating factor for both standard and euglycemic DKA. 18 & 17
• Combined alcohol use, reduced food intake, and liver dysfunction synergistically increase DKA risk. 18